#ryan-white-care-act

#ryan-white-care-act

On that sunny March morning, in a small health center in Lobamba, a rural area of Eswatini, this 32-year-old sex worker has just become one of the first people in the world to receive lenacapavir, a drug that, administered twice a year, offers nearly 100% protection against HIV.

"This argues for the need to sustain such policies and shows that it is possible to right the wrongs retroactively, which is a powerful idea," said Kenneth Michelson, MD, MPH, associate professor of Pediatrics in the Division of Emergency Medicine and a co-author of the study.

Vick thought about a private blood fund run by one of her former employers and the many conversations she's had with other club members about how to support people with AIDS. A new thought emerged: What if Vick and her peers organized their own blood drive and created a fund for folks with AIDS to ensure their continued access?

Congress has kept key drug assistance funding at $900.3 million annually since 2014. New enrollments for state programs jumped 30% from 2022 to 2024, in part because states cut off pandemic-era Medicaid assistance. As of January, at least 18 states have pulled back their Ryan White AIDS Drug Assistance Programs, known as ADAPs, in some way.

During the summer of 2020, at the onset of the Covid pandemic, the documentary director Matt Nadel was back home in Boca Raton, Florida. He remembers one particular evening walk that he took with his father, Phil, as they weathered out those early months. As they strode through the neighborhood, Nadel, now 26, said that the prospect of a vaccine was exciting, but the idea of pharmaceutical executives profiting off a devastating virus left him feeling uneasy.

Black people made up 48 percent of new HIV diagnoses in the South, but only 21 percent of PrEP users in the South; in the Midwest, Black people made up 48 percent of new HIV diagnoses, but only 12 percent of PrEP users. This regional disparity demonstrates the significant gap between HIV burden and preventive medication access among Black populations across different areas of the country.

I'm certainly confident that we're going to have a breakthrough within my career, and I have a good 10 to 15 years left. While antiretroviral (ARV) therapies are extending lives and keeping HIV at bay, and PrEP has the potential to effectively halt transmission of the virus, a cure has remained elusive. That's because the HIV virus itself is elusive, both co-opting the immune system and hiding from it.

In 2026, the US healthcare system is changing. Enhanced Affordable Care Act subsidies have expired, causing premiums for marketplace plans to spike - and pricing some families out of health insurance entirely. President Donald Trump's One Big Beautiful Bill Act will reduce coverage for some patients with Medicaid and funding for hospitals, especially those in rural areas. Costs for Medicare and private insurance are also rising: Employer-based healthcare premiums have increased by 9%, the largest rise in more than a decade.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

The 340B program allows hospitals to buy outpatient drugs at steep discounts, with the purported purpose of helping them fund care for low-income and uninsured patients. The now-axed rebate model would have invited drugmakers to participate voluntarily in a rebate-based discount system. Basically, instead of the provider receiving a discount upfront at purchase, the 340B discount would be applied after purchase via rebate - and subject to tedious data submission requirements.

Your donation allows us to keep sending journalists to speak to both sides of the story. The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.Your support makes all the difference.

By the mid-1980s, the AIDS epidemic had completely gripped the nation. Its victims, primarily queer men, were dying by the thousands. Fear and misinformation reigned supreme, and our government refused to respond to the crisis. Reverend Charles Angel, a community leader and activist who was living with HIV himself, recognized that queer men of color faced additional disparities due to cultural norms and societal inequities.